Journal Information

Statistics

Follow this link to access the full text of the article

452
POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK CYTOGENETICS
M. Dimopoulosa, K. Weiselb, P. Moreauc, L.D.A. Jrd, D. Whitee, J.S. Miguelf, P. Sonneveldg, M. Engelhardth, M. Jenneri, A. Corsoj, J. Dürigk, M. Pavicl, M. Salomom, E. Casaln, R. Jiangn, T. Nguyenn, T. Pelusoo, P. Richardsonp
a National and Kapodistrian University of Athens, Athens, Greece
b Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
c University Hospital Hôtel-Dieu, Nantes, France
d UT Southwestern Medical Center, Dallas, United States
e Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Canada
f Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain
g Erasmus MC Cancer Institute, Rotterdam, the Netherlands
h Universitätsklinikum Freiburg, Freiburg, Germany
i Southampton General Hospital, Southampton, United Kingdom
j Division of Hematology, Hospital of Legnano, Legnano, Italy
k University Hospital Essen, Essen, Germany
l Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hopital Fleurimont, Sherbrooke, Canada
m Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
n Bristol Myers Squibb, Princeton, United States
o Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
p Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States
Ver más
Read
2698
Times
was read the article
1240
Total PDF
1458
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 1 1 2
2025 6 45 12 57
2025 5 58 17 75
2025 4 35 18 53
2025 3 46 15 61
2025 2 41 19 60
2025 1 35 17 52
2024 12 44 15 59
2024 11 36 22 58
2024 10 35 23 58
2024 9 23 22 45
2024 8 26 34 60
2024 7 19 19 38
2024 6 23 19 42
2024 5 22 25 47
2024 4 24 18 42
2024 3 28 21 49
2024 2 18 23 41
2024 1 20 21 41
2023 12 23 24 47
2023 11 41 31 72
2023 10 17 29 46
2023 9 24 31 55
2023 8 14 15 29
2023 7 18 14 32
2023 6 29 17 46
2023 5 31 9 40
2023 4 13 9 22
2023 3 32 13 45
2023 2 18 15 33
2023 1 16 14 30
2022 12 29 21 50
2022 11 26 15 41
2022 10 21 21 42
2022 9 29 22 51
2022 8 26 20 46
2022 7 23 25 48
2022 6 20 22 42
2022 5 25 29 54
2022 4 16 20 36
2022 3 20 21 41
2022 2 14 28 42
2022 1 14 24 38
2021 12 16 22 38
2021 11 15 24 39
2021 10 34 38 72
2021 9 21 32 53
2021 8 29 24 53
2021 7 26 41 67
2021 6 17 28 45
2021 5 16 28 44
2021 4 52 53 105
2021 3 45 36 81
2021 2 19 13 32
2021 1 15 11 26
2020 12 17 25 42
2020 11 18 15 33
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy